Gavreto Capsule
Product Images NDC 71332-006

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gavreto (NDC 71332-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rigel Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gavreto 01)

FDA Label Image

Principal Display Panel (100 mg Capsule Carton)

Principal Display Panel (100 mg Capsule Carton)
This is a medication label for Gavreto (pralsetinib) capsules with NDC 71332-006-60. It is intended for oral use.*
FDA Label Image

Principal Display Panel (100 mg Capsule Carton)

Principal Display Panel (100 mg Capsule Carton)
This text contains information about a medication called Gavreto (pralsetinib) that comes in capsule form for oral use. The medication has an NDC code of 71332-006-90.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.